- THIS ARTICLE
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Hewett-Emmett, D.
- Articles by Tashian, R. E.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Hewett-Emmett, D.
- Articles by Tashian, R. E.
A WIDESPREAD SILENT POLYMORPHISM OF HUMAN CARBONIC ANHYDRASE
III (31 ILE
VAL): IMPLICATIONS FOR EVOLUTIONARY GENETICS
David Hewett-Emmett 1, Rosalind J. Welty 1, and Richard E. Tashian 1
1 Department of Human Genetics, University of Michigan Medical
School, Ann Arbor, Michigan 48109
During amino acid sequence studies of carbonic anhydrase (CA) III, purified from a pool of human skeletal muscles, an electrophoretically undetectable (silent) variation was found at residue 31 which was either valine and/or isoleucine. To distinguish a simple allelic polymorphism from more complex models involving gene duplication, 11 separate CA III samples were purified from individuals of different age and racial backgrounds. Peptide mapping by high performance liquid chromatography and sequencing indicated that four were homozygous for 31-Val, three homozygous for 31-Ile and four were apparent heterozygotes. Since the ratio of Val/Ile at residue 31 was approximately 1.0 in the heterozygotes, the present observations are consistent with a simple allelic polymorphism model. Despite the small sample size, there are preliminary indications that the gene frequencies may differ among racial groups. The finding of this silent allelic polymorphism together with the finding of an electrophoretically detectable polymorphism of CA II permits us to test the linkage of the CA II and CA III genes which appear to have been formed by gene dupliction more than 300 million years ago. The possibility that the Val/Ile variation may represent a neutral mutation is discussed.
Submitted on April 8, 1983Accepted on June 27, 1983